Level of Maternal Antibody Required to Protect Neonates against Early‐Onset Disease Caused by Group B Streptococcus Type Ia: A Multicenter, Seroepidemiology Study
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Because of the difficulty of conducting efficacy trials of vaccines against group B streptococcus (GBS), the licensure of these vaccines may have to rely on studies that measure vaccine-induced antibody levels that correlate with protection. This study estimates the level of maternal antibody required to protect neonates against early-onset disease (EOD) caused by GBS type Ia. Levels of maternal serum IgG GBS Ia antibodies, measured by ELISAs in 45 case patients (neonates with EOD caused by GBS Ia) and in 319 control subjects (neonates colonized by GBS Ia but without EOD) born at > or =34 weeks gestation were compared. The probability of developing EOD declined with increasing maternal levels of IgG GBS Ia antibody (P = .03). Neonates whose mothers had levels of IgG GBS Ia antibody > or =5 microg/mL had an 88% lower risk (95% confidence interval, 7%-98%) of developing type-specific EOD, compared with those whose mothers had levels < 0.5 microg/mL. A vaccine that induces IgG GBS Ia antibody levels > or =5 microg/mL in mothers can be predicted to confer a high degree of type-specific immunity to EOD to their infants.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SERUM-γG-GLOBULIN LEVELS IN NORMAL, PREMATURE, POST-MATURE, AND " SMALL-FOR-DATES " NEWBORN BABIES
Yeung, C. Y., & Hobbs, J. R. (1968) · The Lancet · doi:10.1016/s0140-6736(68)91865-5 · Cited by 145
Cited by
Prevention of Perinatal Group B Streptococcal Disease: (548432006-001)
(2002) · PsycEXTRA Dataset · doi:10.1037/e548432006-001 · Cited by 554
An overview of global GBS epidemiology
Le Doare, K., & Heath, P. T. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.01.009 · Cited by 349
Group B Streptococcal Colonization, Molecular Characteristics, and Epidemiology
Shabayek, S., & Spellerberg, B. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00437 · Cited by 291
Kobayashi, M., Schrag, S. J., Alderson, M. R., Madhi, S. A., Baker, C. J., Sobanjo-ter Meulen, A., Kaslow, D. C., Smith, P. G., Moorthy, V. S., & Vekemans, J. (2019) · Vaccine · doi:10.1016/j.vaccine.2016.12.029 · Cited by 105
Mohammadi, N., Midiri, A., Mancuso, G., Patanè, F., Venza, M., Venza, I., Passantino, A., Galbo, R., Teti, G., Beninati, C., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160249 · Cited by 49
“The innate immune system is extremely effective in controlling GBS replication and most individuals who are colonized with these bacteria do not develop infection even when lacking anti-GBS antibodies [33, 34].”
Metadata
- Authors
- Lin, F. C., Philips III, J. B., Azimi, P. H., Weisman, L. E., Clark, P., Rhoads, G. G., Regan, J., Concepcion, N. F., Frasch, C. E., Troendle, J., Brenner, R. A., Gray, B. M., Bhushan, R., Fitzgerald, G., Moyer, P., & Clemens, J. D.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-10-15
- Volume
- 184
- Issue
- 8
- Pages
- 1022-1028
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2157517505
- Cited by
- 134
- References
- 1
- FWCI
- 6.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.